Company Profile

New Echota Biotechnology is working to develop novel technologies for the manipulation and labeling of the interior of living eukaryotic cells for research diagnostic and eventually therapeutic purposes.Cell penetrating peptides (CPP) offer the tantalizing prospect of delivering a broad palette of user defined protein cargoes through the plasma membranes of eukaryotic cells.CPP adaptor technology not only allows delivery of an extended array of cargoes but has advantages in speed and ease of use as well as safety enhancements compared to current technologies. The initial products derived from this technology wll be a range of research tools for biomedical sciences that will enable researchers to study a wide array of processes in the cell interior.